Cannabis drug testing in California has entered a new phase—and for staffing firms, the rules matter more than ever. With AB 2188 and SB 700 now in effect, many staffing agencies are unsure where drug testing still fits, especially when clients expect safe, compliant placements.
The short answer in 2026: California staffing firms can still drug test for cannabis—but how you test and how you use results has changed.
This guide explains what the law actually says, what’s prohibited, what’s still allowed, and how staffing firms can protect both clients and candidates without violating state law.
What AB 2188 and SB 700 Actually Do (Plain English)
In California, AB 2188 and SB 700 were designed to prevent employment discrimination based on off-duty, off-site cannabis use.
Together, these laws:
- Prohibit adverse employment action based solely on non-psychoactive cannabis metabolites
- Prevent employers from asking about prior cannabis use during hiring
- Restrict reliance on traditional urine tests that detect historical cannabis use
- Apply to both direct employers and staffing agencies acting as employers of record
What they do not do:
- They do not ban drug testing
- They do not eliminate reasonable suspicion testing
- They do not prevent action based on on-the-job impairment
- They do not override federal requirements or safety-sensitive exemptions
Why Staffing Firms Face Higher Risk Than Direct Employers
Staffing agencies operate in a unique position:
- You are often the employer of record
- You screen on behalf of clients with varying risk profiles
- You must comply with state law and client expectations
- A single misstep can affect multiple placements and contracts
In 2026, California staffing firms must ensure their testing programs don’t rely on methods that conflict with AB 2188 and SB 700—especially when cannabis is involved.
The Core Issue: Cannabis Metabolites vs. Impairment
Traditional urine drug tests detect non-psychoactive cannabis metabolites, which can remain in the body for days or weeks after use.
Under AB 2188:
- A positive urine result for THC metabolites alone cannot be used to deny employment
- This creates risk for staffing firms relying on standard urine screening
The law shifts the focus from past use to current impairment—a critical distinction for compliance.
How Staffing Firms Can Still Drug Test for Cannabis (Legally)
1. Use Impairment-Aligned Testing Methods
In 2026, many California staffing firms are shifting away from urine-only cannabis screening and toward saliva (oral fluid) drug testing.
Saliva tests:
- Detect more recent use
- Align better with impairment-based decisions
- Reduce reliance on historical metabolite detection
- Support observed collection
This makes saliva testing a more defensible option when cannabis screening is necessary.
2. Rely on Reasonable Suspicion and Post-Incident Testing
AB 2188 does not prevent staffing firms from acting when there is:
- Observable impairment
- Safety incidents
- Client-reported concerns
- On-site behavior that raises risk
In these cases, drug testing can be used as supporting evidence, especially when paired with documented observations.
3. Understand Safety-Sensitive and Federal Exemptions
Certain roles remain exempt from AB 2188 and SB 700, including:
- Positions requiring federal drug testing
- DOT-regulated roles
- Construction and safety-sensitive jobs defined by law
- Roles involving emergency response, heavy machinery, or public safety
Staffing firms should clearly classify exempt roles and document why testing applies.
4. Update Client Agreements and Candidate Policies
In 2026, compliance is as much about documentation as testing.
Best practices for staffing firms include:
- Updating drug testing policies to reflect AB 2188 and SB 700
- Removing cannabis metabolite-only disqualifiers
- Training recruiters and onsite managers
- Aligning testing protocols with client risk profiles
- Applying policies consistently across candidates
Urine vs. Saliva Testing for California Staffing Firms
Urine Drug Testing
- Still allowed for non-cannabis substances
- Risky when used alone for cannabis decisions
- Best reserved for expanded panels (opioids, fentanyl, amphetamines)
Saliva (Oral Fluid) Drug Testing
- Better aligned with impairment-based enforcement
- Faster results for staffing workflows
- Observed collection reduces disputes
- Increasingly favored in 2026 for cannabis-legal states
Many staffing firms now use hybrid programs: urine testing for non-cannabis drugs, saliva testing where cannabis screening is required.
Common Mistakes Staffing Firms Should Avoid
- Rescinding offers based solely on THC urine results
- Using outdated policies that predate AB 2188
- Treating cannabis like other controlled substances
- Failing to document impairment indicators
- Applying different standards across similar roles
Each of these can expose staffing firms to compliance risk.
Â
How DrugScreens.com Supports California Staffing Firms
DrugScreens.com provides CLIA-waived, FDA-cleared urine and saliva drug test kits designed for modern compliance challenges, including AB 2188 and SB 700.
We help staffing firms:
- Choose testing methods aligned with California law
- Implement saliva testing programs
- Support impairment-based decision-making
- Standardize screening across clients and locations
- Reduce legal and operational risk in 2026
The Bottom Line
AB 2188 and SB 700 didn’t end drug testing for California staffing firms—they changed how it must be done.
In 2026, the safest path forward is:
- Focus on impairment, not history
- Use testing methods that align with the law
- Document observations
- Apply policies consistently
- Educate clients and recruiters
Staffing firms that modernize their screening approach can stay compliant and continue delivering safe, reliable placements.
